IndraLab

Statements

Hydroxychloroquine decreases the amount of toll-like receptors. 1 / 1

| 1

reach

"Interestingly, hydroxychloroquine (Plaquenil), an antimalarial drug, has also been reported to downregulate the expression of toll like receptors (TLRs) and IL-6 production, and therefore may have potential anti-COVID-19 activity [supplementary materials 3]."

32302707

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Hydroxychloroquine decreases the amount of toll-like receptors. 1 / 1

INDRA sources:

Databases

Reading